Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-07

Clinical Trial Update: Remission in Subjects With Crohn's Disease, Open Label Extension [Phase 3]

View source ↗

Summary

A Phase 3 open-label extension study in Crohn's disease reported remission in subjects; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Not disclosed

Snippet

Sponsor: Abbott | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-05-07